Ranibizumab for Macular Edema Secondary to Central and Branch Retinal Vein Occlusion in Patients Younger Than 50 Years of Age

BACKGROUND: To determine the effectiveness of intravitreal ranibizumab (IVR) approach over 1-year follow-up in patients younger than 50 years old with central and branch retinal vein occlusion (RVO) complicated by macular edema (ME). METHODS: Prospective, open-label case series. Patients initiating...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Biomed Res Int
Main Authors: Battaglia Parodi, Maurizio, Romano, Francesco, Arrigo, Alessandro, Mercuri, Stefano, Franceschi, Alessandro, Bandello, Francesco
Formato: Artigo
Idioma:Inglês
Publicado: Hindawi 2020
Assuntos:
Research Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7320288/
https://ncbi.nlm.nih.gov/pubmed/32685489
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2020/4747696
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares